Status:
COMPLETED
HPV Prevalence in Transpersons - a Prospective Study
Lead Sponsor:
Sophie Pils
Conditions:
Papillomavirus Infection
Transsexualism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study, Human Papilloma Virus (HPV) prevalence will be determined once in the urine of 200 trans people. In addition, subjects will be asked to complete a questionnaire about their sexual orien...
Detailed Description
All transpeople who visit the outpatient clinic are asked to participate in the study. After being informed and signing the Informed Consent Form, the subjects are asked to give first-void urine and f...
Eligibility Criteria
Inclusion
- Transpeople
- Age over 18 years
- Sufficient knowledge of German
Exclusion
- Age under 18 years
- Insufficient knowledge of German
Key Trial Info
Start Date :
May 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
203 Patients enrolled
Trial Details
Trial ID
NCT04864951
Start Date
May 2 2021
End Date
November 1 2021
Last Update
March 15 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090
2
Institute of Microbiology and Immunology Faculty of Medicine
Ljubljana, Slovenia, 1000